Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements.
Where this comes from
- Record sourced from PubMed, PMID 41218988.
- Also identified by DOI 10.1136/bmj-2025-086174 and PMC identifier 12599528.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Tarang Sharma and colleagues</b> argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable and sustainable access to costly medicines